
|Articles|July 19, 2021
Pharmacy Times: Week of July 19 Lineup
This week on Pharmacy Times, there are a number of important topics that will be covered and posted throughout the week.
Advertisement
This week on Pharmacy Times, there are a number of important topics that will be covered and posted throughout the week, including:
- In the third video of a series on the approval of aducanumab for Alzheimer disease, Pamela Spicer, MS, senior analyst at Datamonitor with Informa Pharma Intelligence, discussed the data supporting its approval and where some of the controversies originate.
- An article that discusses the challenges involved with the price of specialty medications and how pharmacy benefit managers can help manage the high costs associated with these treatments.
- A pharmacy quiz on treatments for heart failure.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
ADA 2026: Semaglutide Add-On Reduces Glycemic Burden, Cardiometabolic Risk in Older Adults With T2D
2
ADA 2026: Earlier GLP-1 and SGLT-2 Use Recommended From Diabetes Diagnosis, Expert Says
3
Brain Inflammation May Not Drive Persistent Long COVID Symptoms, New Imaging Study Finds
4
New Research Suggests Bempedoic Acid Outperforms Ezetimibe for Heart Health in Patients with Type 2 Diabetes
5





































































































































